Risk Management for Medical Practitioners 2022 
This module gives access to all recorded sessions from the 2021 Board Review Pulmonary Medicine course.
Program content mirrors the content of the exam, as outlined by the ABIM.
| Course Content | ||
| Obstructive Lung Disease | 17.5% | |
| Critical Care Medicine | 15% | |
| Diffuse Parenchymal Lung Disease (DPLD) | 10% | |
| Sleep Medicine, Neuromuscular and Skeletal | 10% | |
| Epidemiology | 2% | |
| Infections | 12% | |
| Neoplasia | 9.5% | |
| Pleural Disease | 5% | |
| Quality, Safety, and Complications | 5% | |
| Transplantation | 2% | |
| Vascular Diseases | 6% | |
| Respiratory Physiology and Pulmonary Symptoms | 4% | |
| Occupational and Environmental Diseases | 2% | |
| Total | 100% | |
